Literature DB >> 34643907

Conditions for Handling and Optimal Storage of Mycolactone.

Jessica Z Kubicek-Sutherland1, Basil I Swanson2, Harshini Mukundan3.   

Abstract

The successful isolation of mycolactone in a laboratory or from a clinical sample relies on proper handling and storage of the toxin. Mycolactone is a light-sensitive and an amphiphilic toxin produced by Mycobacterium ulcerans. The biochemistry of the toxin makes it unstable in aqueous matrices such as blood, which causes it to self-aggregate or present in complex with carrier molecules. This biochemistry also impacts the use of the toxin in vitro, in that it tends to aggregate and stick to substrates in an aqueous environment, which alters its physiological presentation and limits its availability in a sample. Glass materials (i.e., tubes, vials, syringes, plates) should be used when possible to avoid loss of mycolactone sticking to plastic surfaces. Dark containers such as amber vials or aluminum-foil wrapped tubes should be used to avoid photodegradation of the toxin upon exposure to light. Sample storage in organic solvents is ideal for mycolactone stability and recovery; however, this is not always amenable as multiple diagnostic assays might be performed on a single sample (such as PCR or ELISA). In these cases, samples can be stored in an aqueous solution containing a small amount of detergent to enhance recovery of the toxin, and in order to avoid aggregation. Therefore, the downstream manipulations should be carefully considered prior to sample collection and storage. Here we present considerations for the optimal handling and storage of mycolactone in order to obtain quality yield of the toxin for various research and diagnostic applications.
© 2022. The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Amphiphilic; Blood; Buruli ulcer; Mycolactone; Serum; Storage and handling; Tissue samples

Mesh:

Substances:

Year:  2022        PMID: 34643907      PMCID: PMC9009766          DOI: 10.1007/978-1-0716-1779-3_12

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  31 in total

1.  Total synthesis of the mycolactones.

Authors:  Fengbin Song; Steve Fidanze; Andrew B Benowitz; Yoshito Kishi
Journal:  Org Lett       Date:  2002-02-21       Impact factor: 6.005

2.  A ring-closing metathesis (RCM)-based approach to mycolactones A/B.

Authors:  Philipp Gersbach; Andrea Jantsch; Fabian Feyen; Nicole Scherr; Jean-Pierre Dangy; Gerd Pluschke; Karl-Heinz Altmann
Journal:  Chemistry       Date:  2011-10-04       Impact factor: 5.236

3.  A Mycobacterium ulcerans toxin, mycolactone, causes apoptosis in guinea pig ulcers and tissue culture cells.

Authors:  K M George; L Pascopella; D M Welty; P L Small
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

4.  Synthetic variants of mycolactone bind and activate Wiskott-Aldrich syndrome proteins.

Authors:  Anne-Caroline Chany; Romain Veyron-Churlet; Cédric Tresse; Véronique Mayau; Virginie Casarotto; Fabien Le Chevalier; Laure Guenin-Macé; Caroline Demangel; Nicolas Blanchard
Journal:  J Med Chem       Date:  2014-09-02       Impact factor: 7.446

5.  Immunosuppressive properties of the soluble toxin from Mycobacterium ulcerans.

Authors:  M Pimsler; T A Sponsler; W M Meyers
Journal:  J Infect Dis       Date:  1988-03       Impact factor: 5.226

6.  Heterogeneity of mycolactones produced by clinical isolates of Mycobacterium ulcerans: implications for virulence.

Authors:  Armand Mve-Obiang; Richard E Lee; Françoise Portaels; P L C Small
Journal:  Infect Immun       Date:  2003-02       Impact factor: 3.441

7.  Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.

Authors:  Junichiro En; Masamichi Goto; Kazue Nakanaga; Michiyo Higashi; Norihisa Ishii; Hajime Saito; Suguru Yonezawa; Hirofumi Hamada; Pamela L C Small
Journal:  Infect Immun       Date:  2008-03-03       Impact factor: 3.441

8.  Mycolactone diffuses into the peripheral blood of Buruli ulcer patients--implications for diagnosis and disease monitoring.

Authors:  Fred S Sarfo; Fabien Le Chevalier; N'Guetta Aka; Richard O Phillips; Yaw Amoako; Ivo G Boneca; Pascal Lenormand; Mireille Dosso; Mark Wansbrough-Jones; Romain Veyron-Churlet; Laure Guenin-Macé; Caroline Demangel
Journal:  PLoS Negl Trop Dis       Date:  2011-07-19

9.  Accelerated detection of mycolactone production and response to antibiotic treatment in a mouse model of Mycobacterium ulcerans disease.

Authors:  Paul J Converse; Yalan Xing; Ki Hyun Kim; Sandeep Tyagi; Si-Yang Li; Deepak V Almeida; Eric L Nuermberger; Jacques H Grosset; Yoshito Kishi
Journal:  PLoS Negl Trop Dis       Date:  2014-01-02

10.  Mycolactone diffuses from Mycobacterium ulcerans-infected tissues and targets mononuclear cells in peripheral blood and lymphoid organs.

Authors:  Hui Hong; Emmanuelle Coutanceau; Marion Leclerc; Laxmee Caleechurn; Peter F Leadlay; Caroline Demangel
Journal:  PLoS Negl Trop Dis       Date:  2008-10-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.